Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the second-costliest quintile among peers.
Hartford International Opp HLS IB HBIOX
- NAV / 1-Day Return 16.10 / +0.06 %
- Total Assets 862.5 Mil
-
Adj. Expense Ratio
- Expense Ratio 1.000%
- Distribution Fee Level High
- Share Class Type Institutional
- Category Foreign Large Blend
- Investment Style Large Growth
- Min. Initial Investment —
- Status Open
- TTM Yield 0.80%
- Turnover 54%
USD | NAV as of Apr 24, 2024 | 1-Day Return as of Apr 24, 2024, 10:18 PM GMT+0
Morningstar’s Analysis HBIOX
Will HBIOX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 24.0
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Taiwan Semiconductor Manufacturing Co Ltd | 3.60 | 31.0 Mil | Technology |
Samsung Electronics Co Ltd | 3.15 | 27.2 Mil | Technology |
ASML Holding NV | 2.62 | 22.6 Mil | Technology |
Tencent Holdings Ltd | 2.18 | 18.8 Mil | Communication Services |
AstraZeneca PLC | 2.17 | 18.7 Mil | Healthcare |
Shell PLC | 2.14 | 18.4 Mil | Energy |
Novartis AG Registered Shares | 2.12 | 18.3 Mil | Healthcare |
Siemens AG | 2.01 | 17.3 Mil | Industrials |
Novo Nordisk A/S Class B | 1.99 | 17.2 Mil | Healthcare |
Mitsubishi UFJ Financial Group Inc | 1.97 | 16.9 Mil | Financial Services |